Pete Stibbs: Launching New VTE Management Webinar Series at Argon Medical
Pete Stibbs, Senior Vice President, Global Medical Affairs and Medical Director at Argon Medical Devices, shared Argon Medical Devices’s post on LinkedIn:
“I’m excited to share the launch of our new VTE Management Webinar Series at Argon Medical.
Continuous education is essential as the evidence surrounding venous thromboembolism continues to evolve.
From updated clinical guidelines and landmark trials to advances in mechanical thrombectomy and patient selection, our goal is to provide practical, evidence-based discussions that clinicians can apply directly to patient care.
I’m especially pleased that our inaugural session will feature Professor Stephen Black, whose expertise and contributions to venous disease have helped shape the field.
If you’re involved in the management of DVT, PE, or other venous disorders, I hope you’ll join us for what promises to be an outstanding discussion.
I look forward to seeing many colleagues, collaborators, and friends there.”
Argon Medical Devices shared a post on LinkedIn:
“VTE Treatment Is Evolving. Are You Keeping Up?
Join Professor Stephen Black and Argon Medical for the first episode of our new VTE Management Webinar Series: Next-Generation VTE Care – a comprehensive discussion on updated guidelines, intervention strategies, and clinical impact.
Together, we’ll explore:
- How evolving guidelines and landmark trial data are redefining VTE intervention
- Why early intervention matters for long-term outcomes and quality of life
- The technologies and evidence shaping the next generation of VTE treatment
- The value of mechanical thrombectomy in an increasingly outcomes and cost-focused healthcare environment
August 19 | 5:00 PM EDT (10:00 PM BST)
We hope you’ll join us for this conversation – register now to save your seat for Episode One of a series you won’t want to miss.
Click here to register.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 11:35Paulus Kirchhof: Oral Anticoagulation in Atrial Fibrillation After Intracranial Hemorrhage
-
Nov 11, 2026, 11:28Arturo Cesaro: Lp(a) Lowered by 78% but Cardiovascular Outcomes Remain Unchanged
-
Nov 11, 2026, 09:40Diego Martin Rabasedas: Celebrating National Voluntary Blood Donor Day in Argentina
-
Nov 11, 2026, 09:32Nathan Connell: Can a Thrombophilic Factor VIII Variant Inform Future Hemophilia A Therapies?
-
Nov 11, 2026, 09:24Amer Zeidan: Highlights from the 2026 New England Hematologic Disease Symposium
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters